Dec 06, 2013, 01.43 PM IST
Lupin's US subsidiary Lupin Pharmaceuticals Inc (LPI) has launched its generic Fenofibric Acid Delayed- release capsules in the strengths of 45 mg and 135 mg.
Like this story, share it with millions of investors on M3
Lupin launches generic Fenofibric Acid capsules in US
Lupin's US subsidiary Lupin Pharmaceuticals Inc (LPI) has launched its generic Fenofibric Acid Delayed- release capsules in the strengths of 45 mg and 135 mg.
Like this story, share it with millions of investors on M3
Lupin launches generic Fenofibric Acid capsules in US
Lupin's US subsidiary Lupin Pharmaceuticals Inc (LPI) has launched its generic Fenofibric Acid Delayed- release capsules in the strengths of 45 mg and 135 mg.
Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary has launched its generic Fenofibric Acid Delayed- release capsules in the strengths of 45 mg and 135 mg, Lupin said in a statement. The company had earlier received the final approval from the US health regulator (USFDA) for the same, it added.
Also Read: Lupin launches generic GERD drug in the US market
The company's generic products are generic equivalent of AbbVie Inc's Trilipix delayed-release capsules in the same strengths.
As per the IMS MAT September 2013 data, Trilipix delayed- release capsules in the strengths of 45 mg and 135 mg had annual US sales of nearly USD 449.5 million, Lupin said.
"The capsules are indicated as co-administration therapy with statins for the treatment of mixed dyslipidemia, treatment of severe hypertriglyceridemia and primary hyperchol esterolemia or mixed dyslipidemia," it added.
Lupin stock price
On December 06, 2013, at 14:15 hrs Lupin was quoting at Rs 859.90, up Rs 4.50, or 0.53 percent. The 52-week high of the share was Rs 946.35 and the 52-week low was Rs 569.00.
The company's trailing 12-month (TTM) EPS was at Rs 40.18 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 21.4. The latest book value of the company is Rs 108.15 per share. At current value, the price-to-book value of the company is 7.95.
Anda sedang membaca artikel tentang
Lupin launches generic Fenofibric Acid capsules in US
Dengan url
https://kesehatanda.blogspot.com/2013/12/lupin-launches-generic-fenofibric-acid.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Lupin launches generic Fenofibric Acid capsules in US
namun jangan lupa untuk meletakkan link
Lupin launches generic Fenofibric Acid capsules in US
sebagai sumbernya
0 komentar:
Posting Komentar